Le Lézard
Classified in: Health
Subject: SVY

Biological Safety Testing Market is Likely to Touch US$3.08 Bn by 2024, Says TMR


ALBANY, New York, December 10, 2018 /PRNewswire/ --

The revenue generated from the global biological safety testing market stood at US$1.31 bn in 2015. And is likely to touch US$3.08 bn by 2024 end. The global market for biological safety testing market is likely to expand at a robust 10.0% CAGR over the course of forecast period.

     (Logo: https://mma.prnewswire.com/media/664869/Transparency_Market_Research_Logo.jpg )

Instrument of Product Type Dominates Global Market for biological safety testing  

Based on product type, the instrument sector likely to dominate the global market for biological safety testing market in coming years. Compare to the reagents & kits segment, the instrument segment expected to register significant growth throughout the forecast period. On the basis of geography, North America account for maximum share in the global biological safety testing market, further followed by Europe. Also, Asia Pacific is likely to be the emerging economies for the growth of the biological safety testing market owing to rising awareness and rising government healthcare expenses.

Get PDF Brochure for Research Insights at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=18578

Rising demand in pharmaceutical and biological to Drive Market Growth  

Increasing demand in biological industry and pharmaceutical for the biological safety testing is likely to demonstrate significant growth in near future. Also, increasing elderly population, rising awareness toward health in growing economies and rising number of cancer patients are some of the factor supporting growth of the global biological safety and testing market in near future. Moreover, advancement in technology and increasing demand for cost effective products are some of the factors propelling growth of this market in near future.

Request a Sample of Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18578

Also, the growing application of the biological safety testing and enhanced participation by the government likely to boost growth of the global biological safety market in coming years. Bioburden during biologics manufacturing and high microbial detoxification rate are few factors led to the adoption of these testing tools. Therefore, the manufacturers are focused toward implementation of standard practice of manufacturing in order to produce quality products, this is another factor pushing growth of the biological safety testing market at global level.

Request For Discount On This Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=18578

A fresh report published by the Transparency Market Research (TMR) demonstrates highly competitive structure of the global biological safety testing market. This makes the market fragmented in structure, thanks to presence of regional and global players. Also, the major players are strengthening their presence in order to maintain their presence across the globe. The report also includes few leading players operating in the global biological safety testing market such as NuAire, Merck KGaA, WuXi PharmaTech (Cayman) Inc., Charles River Laboratories International, Inc., and Natural Solutions AB & Nordic Scientific.

According to TMR, the manufacturers are focused toward strategic partnership and mergers and acquisitions in order to gain maximum share in the global market for biological safety testing market in coming years.

Request For Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=18578

This review is based on the findings of a TMR report titled "Biological Safety Testing Market (Product Type - Instruments and Reagents & Kits; Test - Endotoxin Tests, Sterility Test, Cell Line Authentication and Characterization Tests, Bioburden Tests, Residual Host Contaminant Detection Tests, Adventitious Agent Detection Tests, Toxicity Tests, and Stability Tests; Application - Vaccines & Therapeutics, Blood & Blood Products, Tissue & Tissue Products, Stem Cell Products, Gene Therapy, and Cellular Therapy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024."

Browse More Healthcare Market Research Reports

More Trending Reports by Transparency Market Research: 

About Us 

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]

Website: http://www.transparencymarketresearch.com
Research Blog: https://theglobalhealthnews.com/



These press releases may also interest you

at 01:24
Sedana Medical AB (publ) announces that all 235 randomized patients have been recruited for its INSPiRE-ICU 1 phase III clinical trial in the United States. Concurrently, the identical INSPiRE-ICU 2 trial is nearing completion, with 23 of 235...

at 01:17
Quarter 1, 2024 - High profitability and strong cash flow Net sales decreased 4.1% to SEK 34,850m (36,352)Organic growth amounted to -4.0%, of which volume accounted for -1.8% and price/mix -2.2%. Excluding restructuring and exited contracts, volumes...

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...



News published on and distributed by: